Atlas Trials

Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C

Clinical trial NCT00203606 · COMPLETED

Trial details

NCT number
NCT00203606
Sponsor
University of Calgary
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis c
Start date
2004-01-01
Primary completion
2009-01-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.